China advances a 10,000-tonne separation plant in Ganzhou while Western supply chains make incremental gains. REEx breaks down what it means for investors.
Element Profile
Lutetium
Symbol
Atomic number
Group
Properties
Density
9.84 g/cm³
Melting point
1663 °C
Boiling point
3402 °C
Crustal abundance
0.8 ppm
Supply Risk
Supply risk
High
Geological scarcity
Extreme
Primary economic driver
PET scanner crystals & Lu-177 cancer drugs
About Lutetium
Lutetium (Lu, atomic number 71) is the last of the lanthanides and one of the least abundant rare earths. Lutetium crystals detect radiation in PET scanners, and the isotope lutetium-177 is the active ingredient in approved cancer drugs. As of October 2026, China was the largest producer and had required export licenses for lutetium since April 2025.
What lutetium is
Lutetium is a hard, silvery metal and one of the heavy rare earth elements. As the final lanthanide, it has the highest melting point and density in the series according to Los Alamos National Laboratory. The U.S. Geological Survey puts its average abundance in Earth's crust at 0.8 parts per million. Among the naturally occurring lanthanides, only thulium is scarcer on those figures (USGS Professional Paper 1802-O).
The physical properties listed on this page are from the Royal Society of Chemistry periodic table.
Discovery and name
French chemist Georges Urbain reported lutetium in 1907 after finding it in a sample of ytterbium oxide. He named it after Lutetia, the Latin name for Paris. Austrian chemist Carl Auer von Welsbach and Charles James at the University of New Hampshire identified it at about the same time, and an international commission credited Urbain in 1909 (LANL). It was the last of the rare earths to be separated, and pure metal was first made in 1953, according to the RSC.
Why PET scanners use lutetium crystals
A PET scanner detects gamma rays given off inside the patient's body. Crystals ring the scanner and turn each gamma ray into a flash of light. Lutetium oxyorthosilicate (LSO) and LYSO, a version that also contains yttrium, are widely used for that job in modern PET detectors. They stop gamma rays well, give off a lot of light and respond quickly, according to a 2015 review by Qingyang Wei.
The same review notes one drawback. About 2.6% of natural lutetium is lutetium-176, which is slightly radioactive, so the crystals produce a low background signal that scanner designers have to manage.
Lutetium-177 in cancer treatment
Lutetium-177 is a radioactive isotope with a half-life of 6.7 days, used to treat neuroendocrine tumors and prostate cancer, according to Dutch isotope producer NRG|PALLAS. Each drug links the isotope to a molecule that binds to a protein on tumor cells.
- Lutathera (lutetium Lu 177 dotatate). The U.S. Food and Drug Administration approved it in January 2018 for adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (Oncology Nursing Society). In April 2024 the FDA extended it to pediatric patients 12 and older with the same tumors (FDA).
- Pluvicto (lutetium Lu 177 vipivotide tetraxetan). The FDA approved it in March 2022 for adults with PSMA-positive metastatic castration-resistant prostate cancer who had already received hormone-pathway drugs and chemotherapy (Oncology Nursing Society). In March 2025 the FDA extended it to adults with PSMA-positive metastatic castration-resistant prostate cancer who had already received an androgen receptor pathway inhibitor, a type of hormone drug. Those patients also had to be considered appropriate to delay taxane-based chemotherapy (FDA). On July 31, 2026, the FDA approved it in combination with an androgen receptor pathway inhibitor for adults with PSMA-positive metastatic prostate cancer that is naive or sensitive to androgen pathway modulation. The FDA said this stage was previously called metastatic hormone-sensitive prostate cancer (FDA).
Research continues on other cancers. In August 2026, REEx covered an early human study pairing gallium-68 and lutetium-177 against kidney cancer that was still at the proof-of-concept stage.
Lutetium-177 is made in nuclear reactors, either by irradiating lutetium-176 or by irradiating ytterbium-176, which decays into lutetium-177 (NRG|PALLAS). The second route uses enriched ytterbium. Canadian firm Kinectrics said in May 2024 that the lutetium-177 supply chain had depended mostly on Russia. It said its new ytterbium-176 production would reduce that reliance.
Catalysts and research uses
Outside medicine, lutetium's main commercial use is as a catalyst for cracking hydrocarbons in oil refineries, according to the RSC. It has also been added to gadolinium gallium garnet crystals once used in magnetic bubble memory (LANL). Beyond those uses, the RSC says lutetium is little used outside research. Geologists use the slow decay of lutetium-176 into hafnium-176 to estimate the ages of meteorites and minerals (LANL).
Where lutetium comes from
Like the other rare earths, lutetium occurs mixed with its neighbors, mainly in monazite and alongside yttrium (RSC, LANL). Heavy rare earths are also concentrated in xenotime and ion-adsorption clays (USGS). USGS reports rare earth reserves for countries including China, Brazil, Australia and the United States, but it does not break out lutetium. Lutetium metal is difficult to extract (RSC). LANL says the cost of producing it is one reason its uses are limited.
Export controls and supply risk
On April 4, 2025, China placed lutetium under export licensing in MOFCOM Announcement No. 18, along with samarium, gadolinium, terbium, dysprosium, scandium and yttrium. In October 2025 China added holmium, erbium, thulium, europium and ytterbium to its controls, then suspended them in November 2025 before they took effect (CIRS). The April controls were not part of that suspension (USGS). As of October 2026, they remained in force.
USGS reported that every U.S. import of lutetium compounds and metals from 2021 through 2024 came from China, and U.S. net import reliance for heavy rare earths was 100% in 2025.
Supply outside China (as of October 2026)
In October 2025, Lynas Rare Earths announced a new heavy rare earth separation plant in Malaysia. Lutetium is in the plant's first set of products. Lynas forecast that capacity within two years, subject to regulatory approvals (Lynas). In July 2026, Lynas said it planned to bring lutetium, gadolinium and yttrium into production from 2027 to 2028, according to Shanghai Metals Market. As of October 2026, REEx found no public report of separated lutetium production outside China. Los Alamos National Laboratory lists Russia and Malaysia among producers without a date.
Recycling
The RSC puts lutetium's recycling rate below 10%. USGS does not report lutetium recycling separately; the heavy rare earths it says were recovered in 2025 came from permanent magnets.
What drives lutetium demand and supply
A 2015 study in the Journal of Sustainable Metallurgy found that lutetium had no high-volume uses and was produced in excess of demand and stockpiled. Lutetium-177 drugs are made from enriched isotopes in reactors. REEx's August 2026 coverage noted that isotope purity and reactor capacity matter more to that market than mine output. For bulk lutetium, the open question in the rare earth supply chain is whether separation outside China reaches steady output while China's licensing stays in place.
Frequently asked questions
What is lutetium used for?
Lutetium is used in LSO and LYSO crystals that detect radiation in PET scanners, as a catalyst for cracking hydrocarbons in oil refining, and in research. Its radioactive isotope lutetium-177 is the active ingredient in FDA-approved drugs for certain neuroendocrine tumors and prostate cancers.
How is lutetium-177 used in cancer treatment?
Lutetium-177 is attached to a molecule that binds to a protein on tumor cells, delivering radiation to those cells. The FDA has approved it in Lutathera for certain neuroendocrine tumors and in Pluvicto for PSMA-positive prostate cancer.
Why do PET scanners use lutetium?
PET scanners detect gamma rays with crystals that turn each ray into a flash of light. Lutetium-based crystals such as LSO and LYSO stop gamma rays well, give off a lot of light and respond quickly.
Where does lutetium come from?
Lutetium is recovered along with other rare earths from minerals such as monazite and xenotime and from ion-adsorption clays. China was the largest producer as of October 2026. All U.S. imports of lutetium compounds and metals from 2021 through 2024 came from China, according to USGS.
Does China restrict lutetium exports?
Yes. Since April 4, 2025, exporting lutetium and its metals, alloys, oxides and compounds from China has required a license under MOFCOM Announcement No. 18. Those April controls were not part of China's later suspension and remained in force as of October 2026.
Primary Uses
- LSO/LYSO scintillator crystals for PET scanners
- Lutetium-177 targeted radionuclide cancer therapy
- Catalyst for hydrocarbon cracking in oil refining
- Research, including lutetium-hafnium dating
Producing Projects
Companies
Found in Products
Recent Articles
China extends rare earth export-control suspensions to 2027 while keeping restrictions on seven key elements, preserving significant trade leverage over
Trump's tariff war exposed U.S. vulnerability in rare earths, where China controls 90%+ of refining and still holds leverage despite 2025 negotiations.
China retains dominance in rare earth separation and magnets as Western projects advance financing and processing—but the supply gap won't close for decades.
Silverado's October 2026 report shows Chinese magnet exports nearing historic levels while controlled compounds stay restricted, revealing key supply
China's rare earth biomedical research targets Lu-177 cancer therapy, NIR-II imaging, and nanoparticles—high value markets requiring specialized supply
Solvent extraction dominates rare earth separation globally, with China controlling 90%+ of refining. Learn why Western challengers are rebuilding—not
China controls 97-98% of heavy rare earth oxide separation. REEx maps CREG's network, foreign feedstock routes, and Shenghe's pending consolidation deal.
Western rare earth investment accelerates, but China retains decisive control over separation, metallization, and magnets. REEx weekly signal holds at 5.9/10.
Scientists recover up to 98% of neodymium from discarded magnets using molten-salt electrolysis, potentially cutting climate impacts by 85% vs
Lynas acquires Meteoric for A$968M, DFARS restrictions loom, and ex-China prices surge. REEx Structural Index rises to 5.8—transition, not independence.
Western rare earth capital is moving downstream, but Dy/Tb separation, metallization, and qualified magnets remain critical bottlenecks ahead of January
Heavy rare earth geology is expanding beyond southern China, but separation capacity remains the critical bottleneck. Here's where the new frontiers stand.
Elon Musk praises China on state TV as Beijing's rare-earth chokepoints constrain U.S. industrial power. What investors must understand about Great Powers
China Northern Rare Earth's full-element separation strategy reveals Beijing's rare-earth advantage is an integrated industrial ecosystem, not just mining
China's rare earth price index hits 263.4, but the real crisis is Western access to exotic heavies like holmium, erbium, and lutetium beyond Dy and Tb.
China Northern Rare Earth expands Dy-Tb separation and full-spectrum processing, widening its lead over Western rivals in critical rare earth supply chains.
CREIA's 261.8 index looks stable, but dysprosium and terbium trade at 4–5× premiums outside China, revealing a fractured global rare earth market.
REEx's Sept 7–12 2026 tracker scores Western rare earth momentum at 5.1/10 as USA Rare Earth breaks ground on a $1.2B South Carolina magnet complex.
China controls 90% of heavy rare earth processing. Gadolinium, lutetium, and yttrium carry billions in U.S. GDP risk—and separation is the real chokepoint.
Ionic Rare Earths and US Strategic Metals sign a 50/50 JV term sheet targeting $100M for NdFeB and SmCo magnet recycling in Missouri, with USSM funding $95M.
Battelle engineers proteins to separate lanthanum and neodymium above 90% purity, but heavy rare earth separation and industrial scale remain unproven.
Silverado's July 2026 data reveals China's export controls hit compounds hard while magnet exports rebound—exposing a two-speed rare earth supply chain.
Yttrium, gadolinium, lutetium and europium are overlooked supply chain chokepoints. State-backed separation capacity is essential for Western industrial
Case Western Reserve University wins DOE funding to develop molten-salt electrolysis for domestic dysprosium and terbium metal production, targeting a key
USA Rare Earth, Energy Fuels, and Lynas made major moves, but China still controls key rare earth choke points as critical deadlines approach.
Gallium-68 and lutetium-177 pair as a 'see-and-treat' kidney cancer theranostic, showing striking tumor uptake in early human trials but serious gastric
Arnold Magnetic Technologies warns that China's 2025 rare earth export controls exposed how little of the permanent-magnet supply chain the West actually
Beijing University of Technology study finds China-specific metrics make medium and heavy rare earths far scarcer than global averages suggest.
China shipped 29 metric tons of yttrium oxide to the US in July, but strategic dependency remains. Learn why this relief is not independence.
South Korean defense firms reportedly reroute Chinese rare earths through Russia and Arab countries as Beijing's 2025 export controls threaten missile and
The U.S. plans 3,655 PAC-3 and THAAD interceptors, but China's rare-earth controls and looming 2027 sourcing rules threaten the supply chains beneath them.
China's November 10 export control deadline and January 2027 DFARS rules create a 92-day window for U.S. defense suppliers to secure critical rare-earth
The U.S. remains 100% import-reliant on heavy rare earths despite $700M in 2025 funding. Financing is not production—America's industrial clock is running out.
China's Rare Earth Price Index holds at 264.6 as heavy rare earths like dysprosium and terbium remain critically scarce outside China, reshaping global
A landmark review identifies 13 research priorities for heavy rare earth supply, urging cleaner extraction and environmental stewardship over simply
China's rare earth index holds near two-year highs, but the real story is tightening heavy rare earth availability and opaque pricing outside China.
China's rare earth price index holds near multi-year highs at 269.2, but daily moves obscure a deeper structural supply crisis threatening Western industries.
GRINM Group met with Xiaomi to align state-backed materials research with EV, robotics, and AI product development, revealing China's integrated
China's rare earth prices are state-influenced benchmarks, not true market prices—and the ex-China market is equally opaque with bespoke bilateral contracts.
China's Rare Earth Price Index hits 273.52, but physical supply constraints—not posted prices—are the real driver shaping global rare earth market power.
China's Rare Earth Price Index holds at 272.5 as heavy rare earths like terbium and dysprosium rise, while supply scarcity increasingly outweighs price as
A University of Helsinki hybrid sorbent shows real promise for cancer-isotope supply chains, not bulk rare-earth refining—here's why the distinction matters.
China's Rare Earth Price Index hits 269.2 as heavy rare earths tighten globally—but investors must look beyond prices to who controls physical supply.
China's rare earth export controls give Washington a real deadline—America must negotiate extensions while building the mine-to-magnet supply chain it
China's Rare Earth Price Index rose to 267.6 on July 2, 2026, but ex-China markets remain opaque, fragmented, and far from transparent price discovery.
China's Rare Earth Price Index holds at 264.9 as dysprosium, terbium, and NdPr prices rise, masking a deeper Western supply crisis for heavy rare earths.
China's Rare Earth Price Index hit 260.9 on June 17, 2026, but opaque pricing, state controls, and China's market dominance complicate what these numbers